Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. Pembrolizumab

   Syndax Pharmaceuticals

   Bladder Cancer

   phase 2 · small molecule · active

   1 trial →

2. Pembrolizumab

   United Therapeutics Europe Ltd

   Castration-resistant Prostate Cancer

   phase 2 · small molecule · active

   1 trial →

3. Pembrolizumab

   Incyte

   Lung Cancer

   phase 2 · small molecule · completed

   2 trials →

4. Pembrolizumab

   United Therapeutics Europe Ltd

   Metastatic Small Intestinal Adenocarcinoma

   phase 2 · mab · active

   1 trial →

5. Pembrolizumab

   United Therapeutics Europe Ltd

   Pancreatic Cancer

   phase 2 · small molecule · active

   1 trial →

6. Pembrolizumab

   United Therapeutics Europe Ltd

   Triple Negative Breast Cancer

   phase 2 · small molecule · active

   1 trial →

7. Pembrolizumab

   Merck KGaA, Darmstadt, Germany

   Melanoma

   phase 2 · mab · completed

   1 trial →

8. Pembrolizumab

   Merck KGaA, Darmstadt, Germany

   Advanced Non-Small Cell Lung Cancer

   phase 2 · mab · completed

   1 trial →

9. Pembrolizumab

   Karyopharm Therapeutics Inc

   Advanced Urothelial Carcinoma

   phase 2 · mab · terminated

   1 trial →

10. Pembrolizumab

    ALX ONCOLOGY HOLDINGS INC

    Ovarian Cancer

    phase 2 · small molecule · active

    1 trial →

11. Pembrolizumab

    TG THERAPEUTICS, INC.

    Hodgkin's Lymphoma

    phase 2 · mab · terminated

    1 trial →

12. Pembrolizumab

    Genmab A/S

    Advanced Endometrial Cancer

    phase 2 · mab · terminated

    1 trial →

13. Pembrolizumab (+) Berahyaluronidase alfa

    Merck KGaA, Darmstadt, Germany

    Squamous Cell Carcinoma

    phase 2 · mab · active

    1 trial →

14. Pembrolizumab (200mg IV for 30 minutes

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 · small molecule · active

    1 trial →

15. Pembrolizumab (KEYTRUDA®) and PDS0101

    PDS Biotechnology Corp

    Metastatic Head and Neck Cancer

    phase 2 · other · completed

    1 trial →

16. Pembrolizumab 200 mg

    Merck KGaA, Darmstadt, Germany

    Metastatic Castration-Resistant Prostate Cancer

    phase 2 · mab · active

    1 trial →

17. Pembrolizumab 200 mg

    Merck KGaA, Darmstadt, Germany

    Non-small Cell Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

18. Pembrolizumab 200 mg IV infusion

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stage IIIB(N2) Non-small Cell Lung Cancer

    phase 2 · mab · active

    1 trial →

19. Pembrolizumab Injection

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    phase 2 · small molecule · completed

    1 trial →

20. Pembrolizumab plus denosumab

    Zealand Pharma A/S

    Renal Cell Carcinoma, Clear Cell

    phase 2 · small molecule · active

    1 trial →

21. Pembrolizumab/Vibostolimab coformulation

    Merck KGaA, Darmstadt, Germany

    Metastatic Non Small Cell Lung Cancer

    phase 2 · mab · completed

    1 trial →

22. Pemebit

    Hospital Authority, Hong Kong

    Adenocarcinoma

    phase 2 · small molecule · completed

    1 trial →

23. Pemetrexe

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Central Nervous System Tumors

    phase 2 · small molecule · active

    1 trial →

24. Pemetrexed

    The First People's Hospital of Lianyungang

    Colorectal Neoplasms

    phase 2 · small molecule · active

    1 trial →

25. Pemetrexed

    Mereo BioPharma Group plc

    Nonsquamous Nonsmall Cell Neoplasm of Lung

    phase 2 · small molecule · completed

    1 trial →

26. Pemetrexed

    Samsung Bioepis NL B.V.

    Colorectal Cancer

    phase 2 · small molecule · active

    1 trial →

27. Pemetrexed Ever Pharma /ml concentrato per so...

    Fondazione Telethon ETS

    Non-small cell lung cancer (NSCLC)

    phase 2 · small molecule · active

    1 trial →

28. Pemetrexed and Reolysin (and safety run-in)

    ONCOLYTICS BIOTECH INC

    Non Small Cell Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

29. Pentasa Sachet depotgranulat for Lynch syndrome, which is increa…

    The George Institute

    Lynch syndrome, which is increasing the risk of developing colorectal cancer

    phase 2 · small molecule · active

    1 trial →

30. Pevonedistat

    Takeda

    Acute Myeloid Leukemia (AML)

    phase 2 · small molecule · completed

    2 trials →

31. Pevonedistat-2002

    Takeda

    Acute Myeloid Leukemia

    phase 2 · small molecule · active

    1 trial →

32. Pexastimogene Devacirepvec (Pexa-Vec)

    Regeneron UK Limited

    Renal Cell Carcinoma

    phase 2 · mab · active

    1 trial →

33. Ph1 INBRX-109 Part 3

    Inhibrx Biosciences

    Advanced or metastatic solid tumors

    phase 2 · small molecule · active

    1 trial →

34. Ph2 INBRX-109 SA CS

    Inhibrx Biosciences

    Unresectable or metastatic conventional chondrosarcoma

    phase 2 · small molecule · active

    1 trial →

35. Phase 1/2A Study of OTP-01 for advanced solid tumors

    Lacuna Pharma Pty Ltd

    advanced solid tumors

    phase 2 · other · active

    1 trial →

36. Phase 1b/2 trial of 5-fluorouracil for metastatic colorectal cancer

    Fondazione Telethon ETS

    metastatic colorectal cancer

    phase 2 · other · active

    1 trial →

37. Phase 1b: APG-115+pembrolizumab

    Ascentage Pharma Group

    Unresectable or Metastatic Melanoma or Advanced Solid Tumors

    phase 2 · small molecule · active

    1 trial →

38. Phase I Study of PM534 Administered to Patients with Advanced Solid Tumors

    Lacuna Pharma Pty Ltd

    Advanced Solid Tumors

    phase 2 · other · active

    1 trial →

39. Phase I Study of PM534 to Patients with Advanced Solid Tumors

    Lacuna Pharma Pty Ltd

    Advances solid tumors

    phase 2 · other · active

    1 trial →

40. Piqray 50 mg and 200 mg film-coated tablets

    Wuhan Createrna Science and Technology Co., Ltd

    metasatic breast cancer, hormon positive, her 2 negative

    phase 2 · small molecule · active

    1 trial →

41. Pirarubicin

    The First People's Hospital of Lianyungang

    Upper Tract Urothelial Carcinoma

    phase 2 · small molecule · active

    1 trial →

42. Placebo

    Cardiff Oncology

    Metastatic Breast Cancer

    phase 2 · small molecule · terminated

    1 trial →

43. Placebo

    NovaBridge Biosciences

    Breast Cancer

    phase 2 · small molecule · terminated

    1 trial →

44. Placebo

    Hospital Authority, Hong Kong

    STOMACH NEOPLASM

    phase 2 · small molecule · active

    1 trial →

45. Pluvicto 1 000 MBq/mL solution for injection/infusion

    Ningbo Cancer Hospital

    Clear Cell Renal Cell Carcinoma (ccRCC)

    phase 2 · small molecule · active

    1 trial →

46. Ponatinib

    Takeda

    Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)

    phase 2 · small molecule · terminated

    1 trial →

47. Ponatinib

    Cardiff Oncology

    Acute Lymphoblastic Leukemia, Adult

    phase 2 · small molecule · active

    1 trial →

48. Ponatinib

    Takeda

    Chronic Myeloid Leukemia

    phase 2 · small molecule · completed

    1 trial →

Frequently asked questions